Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-09

Clinical Trial Update: Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) [NA]

View source ↗

Summary

The RELAX-OAB clinical trial evaluating the AXonics Sacral Neuromodulation System for refractory overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AXonics Sacral Neuromodulation System

Snippet

Sponsor: Axonics, Inc. | Conditions: Overactive Bladder | NA | Status: COMPLETED